Unternehmen HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Aktien
HDST
IL0010954050
HDST
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20.09.15 |
Tamar Raz
CHM | Chairman | 60 | 18.05.14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31.08.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29.07.18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05.07.16 |
Orit Stav
BRD | Director/Board Member | 53 | 01.11.17 |
Tamar Raz
CHM | Chairman | 60 | 18.05.14 |
Merav Kaye
BRD | Director/Board Member | 50 | 28.09.14 |
Asher Elhayany
BRD | Director/Board Member | 71 | 26.12.22 |
Director/Board Member | 58 | 18.07.21 | |
Yuval Adar
BRD | Director/Board Member | 52 | 19.07.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 11 088 522 | 2 772 493 ( 25,00 %) | 0 | 25,00 % |
Unternehmenskontakt
HBL- Hadasit Bio-Holdings Ltd.
Jerusaelm Bio-Park Hadassah Ein-Kerem Campus
91120, Jerusalem
+
http://www.hbl.co.ilSektor
% 1. Jan. | Kap. | |
---|---|---|
+1.51% | 42.75 Mrd. | |
+49.22% | 41.61 Mrd. | |
+8.57% | 41.34 Mrd. | |
-12.36% | 26.59 Mrd. | |
+8.92% | 25.49 Mrd. | |
-25.13% | 18.12 Mrd. | |
+29.17% | 12.24 Mrd. | |
-3.12% | 11.76 Mrd. | |
+6.35% | 11 Mrd. |